AstraZeneca Plc Digital Transformation Strateg Report 2023: Technology Focus, Initiatives, Acquisitions, Partnership and Acquisition Network Map, ICT Budget, and Contracts
12 Jan 2024
DUBLIN, Jan. 12, 2024 /PRNewswire/ -- The "AstraZeneca Plc - Digital Transformation Strategies" company profile has been added to
ResearchAndMarkets.com's offering.
This report provides insight into AstraZeneca's tech activities, including its digital transformation strategies, its innovation programs, its technology initiatives, its estimated ICT budget, and its major ICT contracts.
AstraZeneca Plc (AstraZeneca) is a biopharmaceutical company, which is focused on discovery, production and commercialization of a range of prescription drugs. It develops products related to therapy areas such as respiratory, cardiovascular, renal and metabolic diseases, cancer, autoimmune, infection, and neurological diseases.
The company's product portfolio includes biologics, prescription pharmaceuticals, and vaccines. AstraZeneca sells its products through wholly-owned local marketing companies, distributors, and local representative offices. The company markets its products to primary care and specialty care physicians.
Scope
AstraZeneca is implementing AI technology to gain better understanding of diseases, identify targets for novel medicines, and enable its scientists to discover and develop new medicines. AstraZeneca launched Machine Learning Ledger Orchestration for Drug Discovery (MELLODDY), a research consortium to leverage machine learning technologies and accelerate drug discovery.
AstraZeneca is building internal IT infrastructure and data analytics capabilities to experiment with both structured and unstructured big data to improve data governance and achieve operational efficiencies. AstraZeneca setup an in-house IT division in India, as part of its strategy to transform and streamline its IT operations.
AstraZeneca is focusing on building digital factory of the future by testing and creating integrated solutions in its in-house labs. The technology focus of its in-house labs includes image recognition, AI, electronic records, digital twins, robotics, and automation. AstraZeneca operates Healthcare IoT Innovation Center in China responsible for developing smart healthcare solutions to improve patient experience.
Reasons to Buy
Gain insights into AstraZeneca's tech operations.
Gain insights into its tech strategies and innovation initiatives.
Gain insights into its technology themes under focus.
Gain insights into various product launches, partnerships, and acquisition strategies.
Key Topics Covered:
Overview
Digital Transformation Strategy
Accelerators, Incubators, and Other Innovation Programs
Technology Focus
Technology Initiatives
Acquisitions
Partnership and Acquisition Network Map
ICT Budget and Contracts
Key Executives
A selection of companies mentioned in this report includes
Phyathai 2 Hospital
AliveCor
Mila
Qure.ai
Schrodinger
DeepMatter
BERG
docdok.health
IgniteData
IBM
DNAnexus
For more information about this company profile visit https://www.researchandmarkets.com/r/wlbxvy
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.